| Name | Title | Contact Details |
|---|
OJO Labs is on a mission to fundamentally improve the way people make their most important decisions through the fusion of machine and human intelligence.
At Pushpay, we exist to bring people together by strengthening community, connection, and belonging. We are a high-octane SaaS company changing the way organizations connect and engage with their customers and stakeholders.
FERMÀT is a content native shopping platform that helps brands drive strong conversions and customer acquisition. They work with brands to 3x their ad spend results through custom, content native storefronts. FERMÀT enables unique shopping experiences ...
Provantage Software: a powerful, easy to use time & billing, business intelligence and practice management system.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.